DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry

Status unconfirmed

Conditions studied: Patients at Risk for Developing Contrast-induced Nephropathy

In brief

The purpose of this registry-based study is to evaluate the ongoing, real-world clinical performance and safety of commercially available DyeVert Systems during typical clinical use for patients undergoing coronary or peripheral angiography for diagnostic and/or interventional procedures.

Key facts

Study ID
NCT03825094
Run by
Osprey Medical, Inc
People needed
10000
Starts
2019-05-07
Expected to finish
2023-12-01
Last updated by the study team
2022-04-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.